A detailed history of 683 Capital Management, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, 683 Capital Management, LLC holds 2,070,000 shares of IFRX stock, worth $3.31 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,070,000
Previous 870,000 137.93%
Holding current value
$3.31 Million
Previous $1.34 Million 168.93%
% of portfolio
0.33%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.18 - $1.74 $1.42 Million - $2.09 Million
1,200,000 Added 137.93%
2,070,000 $3.6 Million
Q4 2023

Feb 14, 2024

SELL
$1.25 - $2.75 $1.85 Million - $4.07 Million
-1,480,000 Reduced 62.98%
870,000 $1.42 Million
Q3 2023

Nov 14, 2023

BUY
$2.66 - $4.33 $931,000 - $1.52 Million
350,000 Added 17.5%
2,350,000 $7 Million
Q2 2023

Aug 14, 2023

BUY
$2.05 - $6.1 $4.1 Million - $12.2 Million
2,000,000 New
2,000,000 $8.92 Million

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $70.7M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.